<DOC>
	<DOCNO>NCT02665260</DOCNO>
	<brief_summary>The purpose study determine cantharidin safe effective treatment molluscum contagiosum kid</brief_summary>
	<brief_title>Safety Efficacy Study Topical Cantharidin Treatment Molluscum Contagiosum</brief_title>
	<detailed_description>This double-blind , placebo-controlled trial . Participants recruit Pediatric Dermatology clinic Montefiore Medical Center . One hundred eligible participant randomly assign receive cantharidin 0.7 % topical , cantharidin 0.7 % topical occlusion , placebo , placebo occlusion . Treatments apply week 0 3 ( blind phase ) . At week 6 , participant treat open-label , topical cantharidin 0.7 % without occlusion every 3 week lesion resolve ( open-label phase ) .</detailed_description>
	<mesh_term>Molluscum Contagiosum</mesh_term>
	<mesh_term>Cantharidin</mesh_term>
	<criteria>217years Healthy &lt; 50 molluscum contagiosum lesion Immunosuppressed Oral corticosteroid Sexually active/pregnant</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>